Skip to main content

Advertisement

Correction to: Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer

  • 916 Accesses

The original article was published in Biomarker Research 2017 5:19

Erratum

The original article [1] contains an error in Fig. 3 whereby the trend lines denoting Low & High E-cadherin were mistakenly labelled the opposite way around.

The correct Fig. 3 with appropriately labelled trend lines can be viewed ahead.

Fig. 3
figure1

Kaplan–Meier stratified by E-cadherin expression in breast cancer. Compared with those with low E-cadherin, patients with high expression had superior overall survival (P = 0.002) (c), disease-free survival (P = 0.171) (b), and distant-metastasis-free survival (P = 0.162) (a)

Reference

  1. 1.

    Goto W, et al. Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer. Biomark Res. 2017;5:19.

Download references

Author information

Correspondence to W. Goto.

Additional information

The original article can be found online at https://doi.org/10.1186/s40364-017-0099-2.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Goto, W., Kashiwagi, S., Asano, Y. et al. Correction to: Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer. Biomark Res 6, 9 (2018). https://doi.org/10.1186/s40364-018-0124-0

Download citation